Poseida Therapeutics, Inc. (59) | License Agreements (10)
Recent Contracts
-
Amended and Restated License Agreement, by and between the Registrant and Helmholtz-Zentrum MnchenDeutsches Forschungszentrum fr Gesundheit und Umwelt GmbH, executed as of March...
(Filed With SEC on May 11, 2021)
-
License Agreement, by and between the Registrant and Janssen Biotech, Inc., effective August 3, 2015
(Filed With SEC on June 19, 2020)
-
Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective April 27, 2017
(Filed With SEC on June 19, 2020)
-
Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective August 3, 2018
(Filed With SEC on June 19, 2020)
-
License Agreement, by and between the Registrant and Helmholtz-Zentrum MnchenDeutsches Forschungszentrum fr Gesundheit und Umwelt GmbH, effective May 20, 2016
(Filed With SEC on June 19, 2020)
-
License Agreement, by and between the Registrant and Genus Oncology, LLC, effective October 24, 2019
(Filed With SEC on June 19, 2020)
-
License Agreement, by and between the Registrant and Janssen Biotech, Inc., effective August 3, 2015
(Filed With SEC on January 4, 2019)
-
Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective April 27, 2017
(Filed With SEC on January 4, 2019)
-
Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective August 3, 2018
(Filed With SEC on January 4, 2019)
-
License Agreement, by and between the Registrant and Helmholtz-Zentrum MnchenDeutsches Forschungszentrum fr Gesundheit und Umwelt GmbH, effective May 20, 2016
(Filed With SEC on January 4, 2019)